Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.
about
Potential role of tumor necrosis factor-α in downregulating sex hormone-binding globulinSoluble Fn14 Is Detected and Elevated in Mouse and Human Kidney DiseaseA Randomized Controlled Trial of the Effects of Mindfulness-Based Stress Reduction (MBSR[BC]) on Levels of Inflammatory Biomarkers Among Recovering Breast Cancer Survivors.Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans.Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trialThe function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin.Serum cytokine profile in pediatric Sweet's syndrome: a case report.Dietary intake of trans fatty acids and systemic inflammation in women.Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1.Elevated levels of soluble TNF receptors 1 and 2 correlate with Plasmodium falciparum parasitemia in pregnant women: potential markers for malaria-associated inflammationThe ability to suppress macrophage-mediated inflammation in orbital fat stem cells is controlled by miR-671-5p.Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.Carotid intima media thickness, inflammatory markers, and endothelial activation markers in HIV Patients with lipoatrophy increased at 48 weeks regardless of use of rosiglitazone or placeboRelationship between inflammation and cognitive function in obstructive sleep apneaInflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesionsSalivary cortisol and soluble tumor necrosis factor-α receptor II responses to multiple experimental modalities of acute painCirculating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?Enhanced cortisol increase upon awakening is associated with greater pain ratings but not salivary cortisol or soluble tumor necrosis factor-α receptor II responses to acute pain.Experimental pain ratings and reactivity of cortisol and soluble tumor necrosis factor-α receptor II following a trial of hypnosis: results of a randomized controlled pilot studyNegative and competitive social interactions are related to heightened proinflammatory cytokine activityA non-specific biomarker of disease activity in HIV/AIDS patients from resource-limited environments.Annexin A1 Is Increased in the Plasma of Preeclamptic Women.Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast CancerIncreased tumor necrosis factor receptor 1 expression in human colorectal adenomas.A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R.Tumour necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6) and their soluble receptors (sTNF-alpha-Rp55 and slL-6R) serum levels in systemic lupus erythematodes.Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer.When grief makes you sick: bereavement induced systemic inflammation is a question of genotype.A nested case control study of plasma ICAM-1, E-selectin and TNF receptor 2 levels, and incident primary open-angle glaucoma.Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancerA prospective study of plasma inflammatory markers and risk of colorectal cancer in men.Markers of inflammation and fat distribution following weight loss in African-American and white women.Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study.Inflammatory biomarkers and emotional approach coping in men with prostate cancer.Positive Affect and Inflammatory Activity in Breast Cancer Survivors: Examining the Role of Affective Arousal.Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects.The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
P2860
Q24602925-B708DD4E-4BCF-4AC0-9737-4DB1F097E08DQ27347256-A985AB35-9B13-4FB2-BB44-F2D0649CEF1CQ30252476-1F43B4C3-E0C2-48E5-AACF-770F8753EF6BQ30412754-075DA199-2F6D-4629-842E-A23C6EF9E015Q30580917-38110673-A0A4-47E7-8CC8-0B1922DBEAF8Q33782327-B1329FBD-9C0E-44C6-AADE-9757DBC3DB1EQ33844548-07F0143F-8F6B-4B5B-8509-C7D1348FA1C1Q33862602-BC6DA92A-E489-4AA7-8ACB-7B3C05E33642Q34130165-E17F975B-4768-4973-AAD7-21FA335457FCQ34183422-8EF08AE8-A445-4142-B514-ADA614040979Q34332471-D8FAFFB6-2581-4468-B458-7B149919E6CEQ34586929-24FA8E8A-6EB7-46A0-A385-17A57D4C69FFQ34629246-13D02D90-155A-43DC-B808-B5E0168200B1Q34722085-B9F55791-4D23-467E-8120-0582E7604BBFQ35220175-B9176B92-F264-4411-A064-ADC5B9908EA8Q35229735-10B93F07-DB78-478A-B7C7-77715AAAF569Q35563195-FF04B82D-CB3C-4214-A950-8FB9E898E7F0Q35588773-193B6F55-E2D0-461F-AA6E-2913DFF9810BQ35605801-634461D8-605C-44D7-B2ED-0A262C0D2202Q35609175-123F970A-A85A-413E-AE7E-A89EF269DD3CQ35613125-F33866E2-39D8-40F9-8267-ACE441A03029Q35671375-067BC7C8-2562-4026-892F-AE312835A69AQ35750907-2F22971A-19B6-44D1-9296-9F39C44F71A4Q35780654-96B78B1F-126A-4F16-8E0F-EC0CA076E98AQ35784972-1A043185-BCBB-4022-BB56-986DA9C527B0Q36173493-4C7DB987-4C13-44C7-A005-220B2CC57F86Q36316684-F92FCA8A-C08A-4629-94E3-4E36FF044601Q36401608-5FF0F2E7-791F-44B1-8085-5771C3A211D4Q36628172-AC1EF529-669A-4131-B9C8-96E0BBDB5AF0Q36644563-E59EA529-C01D-4D21-8E37-6FCEE9DFD7E2Q36696189-23EA9348-B4C8-4A1E-BB5C-220494252056Q36766579-A24C6BC1-EBF6-42AB-ACF3-2F2E8B990945Q36813475-68A1E52B-8389-4387-84D6-8F01510E15B3Q36857497-6556E1D8-3394-4327-AFA0-60E23D789419Q36942949-07ACFDA9-6D14-42E2-BC46-681DA5E07275Q36956740-3B1D2AC4-9D75-4C49-9C65-B58307D5EEB5Q36996175-E81F892D-FCF0-4AE8-BFAC-8BB420AC36BDQ37036767-04339A1F-9E1A-4A92-B4B2-8CBF6CD9EFAFQ37067734-3E03DA02-BCA6-4372-8260-FBE9329B571DQ37168309-1CA1E27C-850C-4508-A725-78718411AB6F
P2860
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.
@en
type
label
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.
@en
prefLabel
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis.
@en
P2093
P1476
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis
@en
P2093
A Diez-Ruiz
G Baier-Bitterlich
R Zangerle
P356
10.1111/J.1600-0609.1995.TB01618.X
P577
1995-01-01T00:00:00Z